Founded in Nashville, Tennessee, Harrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded medical and pharmaceutical organization. The company's core mission is to reimagine eyecare by providing a simple and transparent platform that enables ophthalmologists and optometrists to better serve their patients. Harrow Health focuses on delivering high-value FDA-approved drugs and late-stage drug candidates, aiming to enhance the quality of eyecare through its national distribution platform.
Notable affiliated people include industry leaders and investors who have supported Harrow Health's growth and innovation in the ophthalmic market. The company has achieved significant milestones, including establishing a leadership position in the eyecare sector and expanding its product offerings. Harrow Health's impact is evident in its commitment to delivering value to both eyecare providers and patients, thereby enhancing overall patient outcomes and advancing the field of ophthalmology.
